Treatment and Management of Chronic Inflammatory Bowel Diseases: Optimizing Present and Future Therapeutic Choices
- PMID: 36142914
- PMCID: PMC9501929
- DOI: 10.3390/jcm11185267
Treatment and Management of Chronic Inflammatory Bowel Diseases: Optimizing Present and Future Therapeutic Choices
Abstract
Inflammatory bowel diseases (IBD) are chronic relapsing diseases of the gastrointestinal tract of unknown origin, resulting from an aberrant immune response to microbial and gut-specific antigens in genetically susceptible patients [...].
Conflict of interest statement
The author declares no conflict of interest. Lorenzo Bertani received lecture fees from Pharmanutra, Janssen and Takeda, without any influence on this paper.
References
-
- Buie M.J., Quan J., Windsor J.W., Coward S., Hansen T.M., King J.A., Kotze P.G., Gearry R.B., Ng S.C., Mak J.W.Y., et al. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2022 doi: 10.1016/j.cgh.2022.06.030. in press . - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
